Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial

10.1038/nm1632

Saved in:
Bibliographic Details
Main Authors: Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Bardenstein, L.M., Gurovich, I.Y., Morozova, M.A., Mosolov, S.N., Neznanov, N.G., Reznik, A.M., Smulevich, A.B., Tochilov, V.A., Johnson, B.G., Monn, J.A., Schoepp, D.D.
Other Authors: INSTITUTE OF MOLECULAR & CELL BIOLOGY
Format: Article
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/114986
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1038/nm1632